Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Flagrante Delictu who wrote (14930)	2/12/1998 8:05:00 PM
From: Torben Noerup Nielsen	Read Replies (1) \| Respond to of 32384

Bernie, >the circumlocution in yesterday's press release which indicated they >were studying whether the results warranted starting a phase 2. I believe yesterdays statement said that they were studying their options for Phase II trials and that is quite different from your statement above. Am I wrong? I do not think there is any doubt that Phase II trials are warranted. But there are no doubt all sorts of questions about how best to proceed. Cheers, Torben

To: Flagrante Delictu who wrote (14930)	2/12/1998 8:24:00 PM
From: Henry Niman	Respond to of 32384

Speaking of products and H&Q, here is a table from the SF Chronicle published at the conclusion of H&Q: CHART: WHAT'S AHEAD FOR BIOTECH . CLINICAL RESULTS DUE Company Product Treatment for Gilead Preveon AIDS Biochem Pharma Lamivudine Hepatitis B Creative Biomolecules OP-1 Bone repair DUSA Pharmaceuticals Levulan Cancer Ligand Pantretin AIDS (Kaposi's Sarcoma) Ligand Targretin Lymphoma/lung cancer Magainin Cytolex Diabetic foot ulcers Gilead GS4104 Influenza Centocor Avakine Crohn's Dis./arthritis GelTex CholestaGel High cholesterol Amylin Pramlintide Diabetes . NEW PRODUCT LAUNCHES Company Product Treatment for Pathogenesis TOBI Cystic fibrosis Cephalon Provigil Narcolepsy Cephalon-Chiron Myotrophin ALS (Lou Gehrig's disease) Sangstat Cyclosporine Organ transplants Sangstat Thymoglobulin Organ transplants GelTex RenaGel Kidney disease Centocor Avakine Crohn's Dis./ rheum. arthritis Ergo Science Ergoset Diabetes Lifecore InterGel Surgical adhesions IDEC-Genentech Rituxan Lymphoma Source: Hambrecht & Quist, Chronicle research